STENTARELLI, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 6.410
EU - Europa 3.617
AS - Asia 2.241
SA - Sud America 319
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 12.651
Nazione #
US - Stati Uniti d'America 6.328
GB - Regno Unito 2.025
SG - Singapore 729
CN - Cina 728
SE - Svezia 365
IT - Italia 308
HK - Hong Kong 307
DE - Germania 281
BR - Brasile 268
TR - Turchia 160
UA - Ucraina 145
RU - Federazione Russa 126
VN - Vietnam 111
FI - Finlandia 106
FR - Francia 67
BG - Bulgaria 51
CA - Canada 48
IN - India 47
ID - Indonesia 29
MX - Messico 26
ZA - Sudafrica 26
KR - Corea 21
SI - Slovenia 21
JP - Giappone 19
MY - Malesia 16
BE - Belgio 15
BD - Bangladesh 14
IQ - Iraq 14
NL - Olanda 14
EC - Ecuador 13
ES - Italia 13
PL - Polonia 13
AR - Argentina 12
LT - Lituania 10
IE - Irlanda 9
PK - Pakistan 9
AT - Austria 8
MA - Marocco 7
RO - Romania 7
CL - Cile 6
CO - Colombia 6
CZ - Repubblica Ceca 6
PH - Filippine 6
VE - Venezuela 6
CH - Svizzera 5
IR - Iran 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
EU - Europa 4
JO - Giordania 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
AZ - Azerbaigian 3
EG - Egitto 3
ET - Etiopia 3
NG - Nigeria 3
TH - Thailandia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
DK - Danimarca 2
GH - Ghana 2
GR - Grecia 2
HU - Ungheria 2
JM - Giamaica 2
LK - Sri Lanka 2
LU - Lussemburgo 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
ZW - Zimbabwe 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
UY - Uruguay 1
Totale 12.651
Città #
Southend 1.786
Santa Clara 629
Ashburn 556
Fairfield 549
Singapore 476
Woodbridge 465
Chandler 459
Hong Kong 307
Houston 298
Jacksonville 287
Ann Arbor 248
Dearborn 241
Seattle 226
Wilmington 220
Cambridge 199
Beijing 190
Nyköping 159
London 128
Modena 115
Hefei 111
Izmir 104
Los Angeles 102
New York 94
Chicago 93
Dallas 92
Princeton 70
Munich 58
Eugene 51
Sofia 51
Shanghai 49
San Diego 45
The Dalles 41
Helsinki 37
Moscow 36
Salt Lake City 36
Bremen 32
Ho Chi Minh City 32
Council Bluffs 30
São Paulo 28
Boardman 26
Buffalo 25
Redwood City 25
Hanoi 23
Columbus 22
Seoul 20
Tampa 20
Jakarta 19
Turku 19
Milan 18
Phoenix 16
Atlanta 13
Chennai 13
Brussels 12
Falls Church 12
Frankfurt am Main 12
Halifax 12
San Jose 12
Tokyo 12
Toronto 12
Warsaw 12
Bologna 11
Johannesburg 11
Rio de Janeiro 11
Elk Grove Village 10
Lancaster 10
Norwalk 10
San Francisco 10
Sterling 10
Stockholm 10
Bengaluru 9
Brooklyn 9
Dublin 9
Guangzhou 9
Mexico City 9
Montreal 9
Nanjing 9
Poplar 9
Tuscaloosa 9
Dong Ket 8
Faenza 8
Falkenstein 8
Kunming 8
Rome 8
Chengdu 7
Da Nang 7
Denver 7
Ferrara 7
Fremont 7
Orem 7
Augusta 6
Brasília 6
Detroit 6
Dongguan 6
Indiana 6
Jinan 6
Miami 6
Nuremberg 6
Paris 6
Parma 6
Quito 6
Totale 9.407
Nome #
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study 785
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 741
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity 406
Erectile dysfunction is more common in young to middle-aged HIV-infected men than in HIV-uninfected men. 405
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 375
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 352
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 316
Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study 286
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients 285
Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patients 284
Abstract: P784 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 283
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 264
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 252
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 244
Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000-2010. 244
Prediction of hard cardiovascular events in HIV patients 243
HIV patients undergoing second generation antipsychotics show high cardiovascular disease burden 242
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 240
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 237
American College of Cardiology pooled equations and DAD algorithm to predict freedom from cardiovascular events in HIV patients 234
Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment 234
Prevalence and predictors of preclinical coronary heart disease in post-menopause period 228
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women. 226
Body Composition changes in ageing HIV infected patients: the complex interplay between low muscle mass, lipodystrophy and osteopenia. 225
ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 221
Changes with menopause in the distribution of frailty index (FI) in HIV infected women. 221
Should we screen for NAFLD/NASH in HIV patients? 219
MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends 214
Combined use of waist and thigh circumference to identify high-risk,, abdominally obese HIV+ patients. 213
Metabolic alterations in HIV-infected pregnant women: moving to metabolic tailoring of antiretroviral drugs. 209
Predictors of transitions in frailty severity and mortality among people aging with HIV 207
Multiecho MR sequences and high-resolution magic angle spinning (HRMAS)ex-vivo spectroscopy in the qualitative analysis and differentiationbetween steatohepatitis and steatosis 206
HIV-Associated Lipodystrophy: Impact of Antiretroviral Therapy 203
Vitamin D3 supplementation decreases the risk of diabetes mellitus among patients with HIV infection. 202
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 198
MR techiniques in the quantitative assessment of liver steatosis 189
Multimorbidity and functional status assessment 185
HIGH PREVALENCE OF VITAMIN D DEFICIENCY IN A COHORT OF HIV INFECTED PREGNANT AND NON-PREGNANT WOMEN OF CHILDBEARING AGE 184
How do frailty mediate pathway leading to disability 178
Two methods of measuring frailty among people aging with HIV 178
HIGH PREVALENCE OF VITAMIN D DEFICIENCY IN A COHORT OF HIV INFECTED PREGNANT WOMEN AND ITS IMPACT ON PREGNANCY OUTCOME 177
Health transitions in HIV-seropositive individulas undergoing NRTI-based and NRTI-sparing treatment strategies. 173
HR-MAS NMR SPECTROSCOPY FOR CHARACTERIZATION OF STEATOSIC LIVER: FAT QUANTIFICATION FOR A SPECTROSCOPIC DIFFERENTIATION BETWEEN STEATOSIS AND STEATOHEPATITIS 172
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 160
Menopause in HIV-infected women: somewhat different? 156
Impact of Antiretroviral Medications on Fasting Lipid Parameters 155
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodistrophy 150
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 148
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 146
Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients - Reply to Remtulla and Decker 143
Renal hyperfiltration and outcome in HIV-infected subjects. 136
Clinical evaluation is better than risk prediction algorithms to identify patients who need statin therapy. 131
null 49
L’epatopatia non alcolica da accumulo di grasso (NAFLD) in HIV: dallo screening al trattamento 40
Totale 12.794
Categoria #
all - tutte 44.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021870 0 0 0 0 0 127 112 174 89 165 120 83
2021/20221.128 46 159 99 132 19 60 48 72 119 82 160 132
2022/20231.132 118 139 91 117 139 162 9 130 136 20 30 41
2023/2024694 29 47 43 66 155 94 42 85 12 8 43 70
2024/20252.176 65 53 34 158 474 306 144 144 263 76 198 261
2025/20262.164 248 123 312 506 793 182 0 0 0 0 0 0
Totale 12.794